Eyelid Closure in Glaucoma Therapy
Eyelid Closure in Topical Glaucoma Therapy
1 other identifier
interventional
60
1 country
1
Brief Summary
This research is being done to determine if closing your eyelids after you take your glaucoma drops makes them more effective in lowering your eye pressure, and to determine if closing your eyelids for 5 minutes is better than closing them for one minute
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Jan 2009
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2009
CompletedFirst Submitted
Initial submission to the registry
January 29, 2009
CompletedFirst Posted
Study publicly available on registry
January 30, 2009
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 1, 2011
CompletedStudy Completion
Last participant's last visit for all outcomes
January 1, 2011
CompletedSeptember 20, 2012
September 1, 2012
2 years
January 29, 2009
September 19, 2012
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Amount of intraocular pressure lowering
24 hours
Secondary Outcomes (1)
Amount of intraocular pressure lowering
1 hour and one week
Study Arms (2)
Eyelid closure
EXPERIMENTALEyelids will be closed after administration of eye drop
No eyelid closure
ACTIVE COMPARATOREyelids will not be closed after eye drop instillation
Interventions
No intervention will be assigned to this arm
Eligibility Criteria
You may qualify if:
- Age over 18 years, use of one of the three topical prostaglandins (latanoprost, travaprost, or bimatoprost), and no other IOP-lowering eye drops for at least one month.
You may not qualify if:
- Previous laser or incisional surgery for glaucoma, use of punctual plugs, an abnormal slit lamp exam (except for cataract or intraocular lens implant) and incisional eye surgery within the last 6 months.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Johns Hopkins - The Wilmer Eye Institute
Baltimore, Maryland, 21009, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Henry D Jampel, MD
Johns Hopkins University
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- INVESTIGATOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor
Study Record Dates
First Submitted
January 29, 2009
First Posted
January 30, 2009
Study Start
January 1, 2009
Primary Completion
January 1, 2011
Study Completion
January 1, 2011
Last Updated
September 20, 2012
Record last verified: 2012-09